Guardian Pharmacy Services, Inc. $GRDN Stock Position Boosted by Sei Investments Co.

Sei Investments Co. raised its stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 40.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 358,181 shares of the company’s stock after buying an additional 103,177 shares during the period. Sei Investments Co.’s holdings in Guardian Pharmacy Services were worth $13,489,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Boston Partners lifted its stake in shares of Guardian Pharmacy Services by 418.7% in the 3rd quarter. Boston Partners now owns 1,046,877 shares of the company’s stock worth $26,922,000 after acquiring an additional 845,048 shares during the period. Jennison Associates LLC increased its stake in shares of Guardian Pharmacy Services by 609.5% during the first quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock valued at $30,986,000 after acquiring an additional 706,823 shares during the period. Loomis Sayles & Co. L P bought a new stake in Guardian Pharmacy Services during the fourth quarter worth approximately $19,126,000. Millennium Management LLC raised its holdings in Guardian Pharmacy Services by 725.2% during the third quarter. Millennium Management LLC now owns 342,038 shares of the company’s stock worth $8,972,000 after purchasing an additional 300,587 shares in the last quarter. Finally, TimesSquare Capital Management LLC lifted its position in Guardian Pharmacy Services by 21.9% in the fourth quarter. TimesSquare Capital Management LLC now owns 1,048,136 shares of the company’s stock worth $31,538,000 after purchasing an additional 187,963 shares during the period.

Guardian Pharmacy Services Price Performance

NYSE GRDN opened at $41.20 on Friday. The company has a 50 day simple moving average of $40.70 and a 200-day simple moving average of $36.69. The firm has a market capitalization of $2.05 billion, a price-to-earnings ratio of 49.64, a price-to-earnings-growth ratio of 2.69 and a beta of 0.05. Guardian Pharmacy Services, Inc. has a 52-week low of $19.30 and a 52-week high of $44.00.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.24 by $0.05. The business had revenue of $336.60 million during the quarter, compared to analysts’ expectations of $329.89 million. Guardian Pharmacy Services had a net margin of 3.64% and a return on equity of 30.72%. The firm’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same period last year, the company posted $0.22 earnings per share. On average, analysts predict that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current year.

Analyst Ratings Changes

GRDN has been the subject of a number of research reports. Zacks Research lowered Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Oppenheimer boosted their price objective on Guardian Pharmacy Services from $38.00 to $43.00 and gave the stock an “outperform” rating in a research note on Thursday, May 7th. Bank of America upped their price objective on Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a “buy” rating in a report on Wednesday, June 17th. Weiss Ratings cut Guardian Pharmacy Services from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, May 11th. Finally, Wall Street Zen lowered Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. Seven analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Guardian Pharmacy Services presently has a consensus rating of “Moderate Buy” and a consensus target price of $42.83.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.